enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
12.01
+0.09 (0.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed
enVVeno Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -19.47 | -21.82 | -23.52 | -24.67 | -16.53 | |
| Depreciation & Amortization | 0.49 | 0.53 | 0.55 | 0.53 | 0.45 | |
| Loss (Gain) From Sale of Investments | 0.39 | 0.02 | -0.47 | -0.05 | - | |
| Stock-Based Compensation | 3.42 | 4.14 | 5.2 | 8.99 | 6 | |
| Other Operating Activities | - | - | - | - | -0.31 | |
| Change in Accounts Payable | 0 | 0.7 | -0.18 | 0.09 | -0.83 | |
| Change in Other Net Operating Assets | -0.4 | -0.41 | -0.43 | -0.51 | -0.63 | |
| Operating Cash Flow | -15.57 | -16.84 | -18.86 | -15.62 | -11.85 | |
| Capital Expenditures | -0.01 | -0.04 | -0.03 | -0.12 | -0.37 | |
| Investment in Securities | 15.86 | 1.37 | -7.84 | -34.44 | - | |
| Investing Cash Flow | 15.86 | 1.34 | -7.87 | -34.55 | -0.37 | |
| Issuance of Common Stock | 1.02 | 13.64 | 25.79 | - | 39.33 | |
| Other Financing Activities | - | - | - | - | 18.27 | |
| Financing Cash Flow | 1.02 | 13.64 | 25.79 | - | 57.61 | |
| Net Cash Flow | 1.31 | -1.87 | -0.94 | -50.17 | 45.39 | |
| Free Cash Flow | -15.57 | -16.88 | -18.89 | -15.73 | -12.22 | |
| Free Cash Flow Per Share | -26.44 | -34.44 | -53.75 | -58.14 | -49.26 | |
| Levered Free Cash Flow | -9.21 | -9.67 | -10.36 | -6.33 | -5.82 | |
| Unlevered Free Cash Flow | -9.21 | -9.67 | -10.36 | -6.33 | -5.82 | |
| Change in Working Capital | -0.4 | 0.29 | -0.62 | -0.42 | -1.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.